Geode Capital Management, LLC Aptorum Group LTD Transaction History

Geode Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.42 - $11.7 $2,331 - $64,934	5,550 Added 1.6%	353,302 $194,000
Q3 2022 Nov 14, 2022	BUY	$1.14 - $12.9 $17,082 - $193,306	14,985 Added 4.5%	347,752 $399,000
Q2 2022 Aug 12, 2022	BUY	$0.95 - $1.67 $5,624 - $9,886	5,920 Added 1.81%	332,767 $455,000
Q1 2022 May 13, 2022	BUY	$1.22 - $2.28 $7,899 - $14,762	6,475 Added 2.02%	326,847 $545,000
Q4 2021 Feb 11, 2022	BUY	$1.5 - $2.64 $12,210 - $21,489	8,140 Added 2.61%	320,372 $480,000
Q3 2021 Nov 12, 2021	BUY	$2.39 - $3.22 $26,311 - $35,448	11,009 Added 3.65%	312,232 $799,000
Q2 2021 Aug 13, 2021	BUY	$2.37 - $3.43 $674,018 - $975,478	284,396 Added 1690.12%	301,223 $962,000
Q4 2020 Feb 12, 2021	BUY	$2.03 - $2.89 $34,158 - $48,630	16,827 New	16,827 $41,000

Ticker APM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,265,500
Market Cap $8.62M
Description
Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.